MOUNTAIN VIEW, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy ...

The global leader for SEEG depth electrodes, resuming direct sales in the U.S. following the contractual end of its distribution partnership with NeuroPace. CHAUDEFONTAINE, FRANCE, April 3, 2025 ...

While both the sEEG device and the Evo cortical electrode, which earned NeuroOne’s first-ever FDA clearance back in 2019, are designed to be used as diagnostic tools for neurological conditions ...

Under the terms of the agreement, NeuroPace will have exclusive rights to promote and sell stereoelectroencephalography (SEEG) electrodes in the U.S. DIXI will continue to support U.S. physicians ...

Under the terms of the agreement, NeuroPace will have exclusive rights to promote and sell stereoelectroencephalography (SEEG) electrodes in the U.S. DIXI will continue to support U.S. physicians as ...